Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Lin Su
B-Cell Lymphoma Immunotherapy Using TLR9-targeted Oligonucleotide STAT3 Inhibitors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Cell-Selective Oligonucleotide STAT3 Inhibitor for Immunotherapy of Human Acute Myeloid Leukemia
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Inhibition of the STAT3 Target SGK1 Sensitizes Diffuse Large B Cell Lymphoma Cells to AKT Inhibitors
Blood Cancer Journal
Oncology
Hematology
Beta-Adrenergic Signaling Impairs Anti-Tumor CD8+ T Cell Responses to B Cell Lymphoma Immunotherapy
Cancer immunology research
Cancer Research
Immunology
TLR9 Agonists Induced Cell Death in Burkitt's Lymphoma Cells Is Variable and Influenced by TLR9 Polymorphism
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Integration of HIV-1 Caused STAT3-associated B Cell Lymphoma in an AIDS Patient
Microbes and Infection
Infectious Diseases
Immunology
Microbiology
Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma
Scientific Reports
Multidisciplinary
Regulatory B Cell Production of IL-10 Inhibits Lymphoma Depletion During CD20 Immunotherapy in Mice
Journal of Clinical Investigation
Medicine
B Cell-Intrinsic TLR9 Expression Is Protective in Murine Lupus
Journal of Clinical Investigation
Medicine
Inhibition of Β-Catenin/B Cell Lymphoma 9 Protein−protein Interaction Using Α-Helix–mimicking Sulfono-Γ-AApeptide Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
